William Blair Investment Management LLC Has $37.45 Million Position in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

William Blair Investment Management LLC boosted its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 44.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 812,825 shares of the company's stock after acquiring an additional 248,888 shares during the quarter. William Blair Investment Management LLC owned approximately 2.90% of Establishment Labs worth $37,447,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of Establishment Labs by 1.8% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 35,236 shares of the company's stock valued at $1,525,000 after acquiring an additional 632 shares in the last quarter. R Squared Ltd acquired a new position in Establishment Labs during the fourth quarter valued at approximately $36,000. Swiss National Bank grew its holdings in Establishment Labs by 2.7% during the fourth quarter. Swiss National Bank now owns 38,500 shares of the company's stock valued at $1,774,000 after purchasing an additional 1,000 shares during the last quarter. Verition Fund Management LLC raised its position in shares of Establishment Labs by 22.8% in the third quarter. Verition Fund Management LLC now owns 9,400 shares of the company's stock valued at $407,000 after purchasing an additional 1,746 shares during the period. Finally, Handelsbanken Fonder AB lifted its stake in shares of Establishment Labs by 32.3% in the fourth quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock worth $378,000 after buying an additional 2,000 shares during the last quarter. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Establishment Labs Stock Performance

NASDAQ:ESTA traded up $0.21 during trading hours on Friday, hitting $39.67. 493,686 shares of the company traded hands, compared to its average volume of 421,304. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. The stock has a market capitalization of $1.14 billion, a price-to-earnings ratio of -15.38 and a beta of 0.95. The firm has a 50-day moving average of $35.82 and a 200 day moving average of $40.91. Establishment Labs Holdings Inc. has a twelve month low of $28.16 and a twelve month high of $60.12.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The company had revenue of $44.51 million during the quarter, compared to the consensus estimate of $44.45 million. On average, analysts forecast that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Analysts Set New Price Targets

Separately, Stephens reiterated an "overweight" rating and issued a $52.00 target price on shares of Establishment Labs in a research note on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $57.40.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.